These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30229824)

  • 1. Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.
    Shi YX; Ye BL; Hu BR; Ruan XJ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5525-5530. PubMed ID: 30229824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
    Min C; Zhang A; Qin J
    Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
    Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
    Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.
    Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-1298 expression correlates with prognosis and inhibits cell proliferation and invasion of gastric cancer.
    Qiu ZK; Liu N; Zhao SF; Ding AP; Cheng G; Qiu WS; Qi WW
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1672-1679. PubMed ID: 29630111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.
    Zhu XP; Wang XL; Ma J; Fang YF; Zhang HJ; Zhang C; Feng MC
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SNORA21 expression is upregulated and acts as a novel independent indicator in human gastric cancer prognosis.
    Liu CX; Qiao XJ; Xing ZW; Hou MX
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5519-5524. PubMed ID: 30229823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-Regulation of Plasma miR-23b is Associated with Poor Prognosis of Gastric Cancer.
    Zhuang K; Han K; Tang H; Yin X; Zhang J; Zhang X; Zhang L
    Med Sci Monit; 2016 Feb; 22():356-61. PubMed ID: 26835790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.
    Zhang J; Tian ZL; Zhang WT; Cheng LM; Liu J; Cao YX; Zhang ZR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2803-2808. PubMed ID: 31002131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-769-5p functions as an oncogene by down-regulating RYBP expression in gastric cancer.
    Luan PB; Jia XZ; Yao J
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6699-6706. PubMed ID: 32633360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
    Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
    Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells.
    Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G
    Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients.
    Feng R; Sah BK; Beeharry MK; Yuan F; Su L; Jin X; Yan M; Liu B; Li C; Zhu Z
    Cancer Biomark; 2018 Feb; 21(2):335-343. PubMed ID: 29171987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
    Kong Y; Ning L; Qiu F; Yu Q; Cao B
    Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced miR-490-3p expression is associated with poor prognosis of Helicobacter pylori induced gastric cancer.
    Qu M; Li L; Zheng WC
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3384-3388. PubMed ID: 28829504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
    Ren C; Chen H; Han C; Fu D; Wang D; Shen M
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
    Ma G; Dai W; Sang A; Yang X; Gao C
    Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
    Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
    Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
    Cui Z; Zheng X; Kong D
    World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.